1. An inclusion complex comprising a substantially pure terpenglikozid and at least one cyclodextrin, wherein the inclusion complex is greater than the solubility of the solubility of a substantially pure terpenglikozida takovogo.2 like. An inclusion complex according to claim 1, wherein the at least one substantially pure terpenglikozid has a shape selected from the anhydrous polymorphic forms, solvate polymorphic forms, amorphous forms thereof and kombinatsii.3. An inclusion complex according to claim 2, wherein the substantially pure form is in terpenglikozid gidrata.4. An inclusion complex according to claim 1, wherein the substantially pure rebaudioside terpenglikozid selected from A rebaudioside B rebaudioside C rebaudioside D rebaudioside E rebaudioside F stevioside steviolbioside dulkozida A rubuzozida steviol steviol-13-O-β-D-glycoside suaviozida A suaviozida B suaviozida G suaviozida H suaviozida I suaviozida J izosteviola complex β-D-glyukopiranozilovogo ether 13 - [(2-O- (3-O-α-D-glucopyranosyl) -β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl) oxy ] Kaur-16-ene-18-oic acid complex β-D-glyukopiranozilovogo ether 13 - [(2-O-β-D-glucopyranosyl-3-O- (4-O-α-D-glucopyranosyl) -β-D-glucopyranosyl-β-D-glucopyranosyl) oxy ] Kaur-16-ene-18-oic acid complex β-D-glyukopiranozilovogo ether 13 - [(3-O-β-D-glucopyranosyl-β-D-glucopyranosyl) oxy] Kaur-16-ene-18-oic acid complex β-D-glyukopiranozilovogo ester 13-hydroxy-Kaur-16-ene-18-oic acid complex β-D-glyukopiranozilovogo ester 13-methyl-16-okso17 norkauran-18-oic acid complex β-D-glyukopiranozilovogo ether 13 - [(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl) oxy] Kaur-15-ene-18-oic acid 13 - [(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-Ch1. Комплекс включения, содержащий по существу чистый терпенгликозид и по меньшей мере один циклодекстрин, причем растворимость комплекса включения превышает растворимость по существу чистого терпенгликозида как такового.2. Комплекс включения
